Pathogenesis of osteoporotic hip fractures

Clinical Cornerstone

Volumn 5, Issue SUPPL. 2, 2003, Pages

  McClung, Michael R ^a  

^a PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; ESTROGEN; GESTAGEN; RALOXIFENE; RISEDRONIC ACID; VITAMIN D;

ACCIDENT PREVENTION; ADULT; AGE; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TURNOVER; DIET SUPPLEMENTATION; DISEASE COURSE; ELDERLY CARE; EXERCISE; FALLING; FAMILY HISTORY; FEMALE; FRAGILITY FRACTURE; HEALTH STATUS; HIP FRACTURE; HUMAN; INDIVIDUALIZATION; MALE; MUSCLE STRENGTH; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PREDICTION; PROTECTIVE EQUIPMENT; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SEX DIFFERENCE; VERTEBRA FRACTURE; VISUAL IMPAIRMENT; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ACCIDENTAL FALLS; AGE FACTORS; BONE DENSITY; HIP FRACTURES; HUMANS; NUTRITIONAL STATUS; OSTEOPOROSIS; RISK FACTORS;

EID: 0345257293     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(03)90044-5     Document Type: Article

References (17)

1. National Osteoporosis Foundation. Prevalence of low bone mass and osteoporosis affects significant percentage of men and women in U.S. 50 and older. Available at: www.nof.org. Accessed May 8, 2003.
2. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7: 407-413.
3. Cooper C. Epidemiology of osteoporosis. Osteoporos Int. 1997;9:S2-S8.
4. Kanis JA, Johnell O, Oden A, et al. Ten-year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int. 2001; 12:989-995.
5. Dargent-Molina P, Favier F, Grandjean H, et al. Fall-related factors and risk of hip fracture: The EPIDOS Prospective Study. Lancet. 1996;348: 145-149.
6. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ. 1994;308:1081-1082.
7. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: Randomised double blind controlled trial. BMJ. 2003;326:469.
8. Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288: 321-333.
9. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA. 1999;282:637-645.
10. Chesnut CH III, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The Prevent Recurrence of Osteoporotic Fractures (PROOF Study). Am J Med. 2000;109: 267-276.
11. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348:1535-1541.
12. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial. JAMA. 1998;280:2077-2082.
13. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344:333-340.
14. Bone HG, Downs RW, Tucci JR, et al. Dose-response relationships for alendronate treatment in osteoporotic elderly women. J Clin Endocrinol Metab. 1997;82:265-274.
15. Schott AM, Cormier C, Hans D, et al. How hip and whole-bone mineral density predict hip fracture in elderly women: The EPIDOS Prospective Study. Osteoporos Int. 1998;8:247-254.
16. Day L, Fildes B, Gordon I, et al. Randomised factorial trial of falls prevention among older people living in their own homes. BMJ. 2002;325:128.
17. Kannus P, Parkkari J, Niemi S, et al. Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med. 2000;343:1506-1513.